FG codeine ban, Emzor Pharma closure a knee jerk response – Experts

| May 9, 2018

article image
The recent ban on codeine-containing cough syrup by the Federal Government, shutting down Emzor Pharmaceuticals Ind. Ltd., Peace Standard Pharmaceutical Limited and Bioraj Pharmaceutical Limited is a knee jerk response to the drug abuse problem experts have said. The ban is echoing in the public space over the drastic measure. Experts want a more logical and comprehensive policy to tackle the incomprehensible and remote causes of this weird and worsening addiction in the country. Cheta Nwanze , Partner at SBM intelligence said the ban is sending a very poor signal about the government and the regulatory agencies. “Codeine is an opiod but not necessarily an essential ingredient but it very effective,” Nwanze said. “Has there been a study for medical evidence, does the country know how many people who depend on medicine with codeine, the knee jerk banning is just an action which if carried out sends a very poor signal to businesses anytime that anything can be at risk.” The Nigerian senate in October 2017 estimated that about 3 million bottles of codeine is consumed daily in Kano and Jigawa States alone. Millions of bottles are consumed all over the country which is rising to epidemic proportions with grave consequences for the youths.

Spotlight

Ingenious Med

Ingenious Med offers usable solutions that simplify workflows. Our intuitive, physician-designed, mobile/cloud based solution and professional implementation and services teams help increase revenues, align care teams and reduce the cost of care.

OTHER ARTICLES

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | March 6, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Spotlight

Ingenious Med

Ingenious Med offers usable solutions that simplify workflows. Our intuitive, physician-designed, mobile/cloud based solution and professional implementation and services teams help increase revenues, align care teams and reduce the cost of care.

Events